Granted Patent B2

US 12,329,943 · App. 17/590,175 · Granted Jun 17, 2025

Inventors: Francisca Tan-Malecki (Westlake Village, CA); Ronald Forster (Simi Valley, CA); Scott M. Nunn (San Mateo, CA); Mark D. Holt (Moorpark, CA); Son C. Tran (San Francisco, CA); Sheldon Moberg (Thousand Oaks, CA)

Assignee: AMGEN INC.

A61M5/31A61M5/1452A61M5/148A61M5/158A61M5/162A61M5/1626A61M5/172A61M5/2466B65B3/003B65B7/2821B65B55/08B65B55/10A61M5/14244A61M5/2455A61M2005/247A61M2005/2474A61M2005/3114A61M2207/00

Abstract

Claims (31)

1. An injector comprising:

a container including a first wall with an interior surface and a septum with an interior surface, the interior surfaces of the first wall and the septum at least partially defining a reservoir, wherein the septum is fixed with respect to the first wall of the container;

a stopper movably disposed in the container;

a needle having at least a first position and a second position; and

a second wall positioned exterior to the septum such that the septum and the second wall at least partially define an enclosed space disposed between the septum and the second wall, wherein a point of the needle is disposed adjacent to the second wall in the first position and disposed through the septum in the second position,

wherein the needle and the second wall are configured such that the needle moves with respect to the second wall in moving from the first position to the second position.

2. The injector of claim 1 , wherein the second wall is free from contact with the septum.

3. The injector of claim 1 , wherein the second wall is immovable with respect to the first wall of the container.

4. The injector of claim 1 , wherein the second wall is coupled with the needle such that the point of the needle penetrates the second wall in the first position.

5. The injector of claim 1 , comprising an actuator configured to move the needle from the first position to the second position.

6. The injector of claim 5 , comprising a mechanical input device coupled to the actuator.

7. The injector of claim 5 , comprising an electrical or electro-mechanical input device coupled to the actuator.

8. The injector of claim 1 , wherein the septum comprises a flexible unitary wall.

9. The injector of claim 1 , comprising:

an injection needle for insertion into a patient; and

a flexible tubing connecting the needle and the injection needle.

10. The injector of claim 1 , wherein the second wall comprises a second septum and the needle is disposed through the second septum in the second position.

11. The injector of claim 1 , wherein the injector is manufactured with the point of the needle disposed in the enclosed space in the first position.

12. The injector of claim 1 , wherein the point of the needle is disposed in the enclosed space prior to any user-initiated movement of the needle with respect to the container.

13. The injector of claim 1 , wherein the injector is packaged with the point of the needle disposed in the enclosed space in the first position.

14. The injector of claim 1 , wherein the point of the needle is initially, prior to use, disposed stationarily in the enclosed space in the first position.

15. The injector of claim 1 , comprising a drug disposed in the container, the drug comprising at least one of: a granulocyte colony-stimulating factor, a pegylated granulocyte colony-stimulating factor, a PCSK9-specific antibody, an erythropoiesis stimulating agent, a TNF blocker, an interleukin-receptor specific antibody, an IGF-receptor specific antibody, or a TGF-specific antibody.

16. A method of assembling an injector, the method comprising:

filling a reservoir of a container with a drug, the container including a first wall with an interior surface and a septum with an interior surface, the reservoir after filling being defined at least by the interior surface of the first wall of the container, and the interior surface of the septum of the container, wherein the septum is fixed with respect to the first wall of the container;

providing a stopper movably disposed in the container;

positioning a second wall exterior to the septum such that the septum and the second wall at least partially define an enclosed space disposed between the septum and the second wall; and

positioning a point of a needle adjacent to the second wall to define a first position of the needle, the point of the needle being configured to be disposed through the septum in a second position of the needle, the needle and the second wall being configured such that the needle moves with respect to the second wall in moving from the first position to the second position.

17. The method of claim 16 , wherein the second wall is free from contact with the septum.

18. The method of claim 16 , wherein the second wall is immovable with respect to the first wall of the container.

19. The method of claim 16 , wherein the second wall is coupled with the needle such that the point of the needle penetrates the second wall in the second position.

20. The method of claim 16 , the drug comprising at least one of: a granulocyte colony-stimulating factor, a pegylated granulocyte colony-stimulating factor, a PCSK9-specific antibody, an erythropoiesis stimulating agent, a TNF blocker, an interleukin-receptor specific antibody, an IGF-receptor specific antibody, or a TGF-specific antibody.

Assignments (1)

Continuity (6)

References Cited (400)